About Ganesh Iyer
Form D filings for Opprtna Therapeutics in 2024 list Ganesh Iyer as president and director.
Ganesh Iyer first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Ganesh Iyer in the role, so the role may have started earlier or lasted longer.